{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:46:22Z","timestamp":1784609182421,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118726","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:19:06Z","timestamp":1762269546000},"page":"118726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Inhibition of ATP citrate lyase does not affect muscle mitochondrial activity in apoE-\/- mice"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-989X","authenticated-orcid":false,"given":"Chiara","family":"Macchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Fichtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnim","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-9230","authenticated-orcid":false,"given":"Alessandra Stefania","family":"Rizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5892-9857","authenticated-orcid":false,"given":"Chiara","family":"Pavanello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-5208","authenticated-orcid":false,"given":"Jurgen","family":"Gindlhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5799-3666","authenticated-orcid":false,"given":"Simone","family":"Nerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare R.","family":"Sirtori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8196-5696","authenticated-orcid":false,"given":"Elena","family":"Osto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-0899","authenticated-orcid":false,"given":"Stefano","family":"Carugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3245-2872","authenticated-orcid":false,"given":"Marco","family":"Busnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Magnaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-7061","authenticated-orcid":false,"given":"Massimiliano","family":"Ruscica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10258","key":"10.1016\/j.biopha.2025.118726_bib1","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Diseases","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.biopha.2025.118726_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118726_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications","volume":"21","author":"Ference","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118726_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2025.118726_bib5","article-title":"Optimal implementation of the 2019 ESC\/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study","volume":"31","author":"Brandts","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"issue":"11","key":"10.1016\/j.biopha.2025.118726_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/eurheartj\/ehv641","article-title":"Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study","volume":"37","author":"Nielsen","year":"2016","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.biopha.2025.118726_bib7","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1093\/cvr\/cvac020","article-title":"Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications","volume":"118","author":"Ruscica","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"17","key":"10.1016\/j.biopha.2025.118726_bib8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.biopha.2025.118726_bib9","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N. Engl. J. Med"},{"issue":"7","key":"10.1016\/j.biopha.2025.118726_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/14656566.2019.1583209","article-title":"ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials","volume":"20","author":"Ruscica","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.biopha.2025.118726_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11883-022-01054-2","article-title":"Bempedoic Acid: for Whom and When","volume":"24","author":"Ruscica","year":"2022","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.biopha.2025.118726_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","author":"Mach","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2025.118726_bib13","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2025.118726_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/ATVBAHA.116.308963","article-title":"Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Ldlr(-\/-) Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid","volume":"37","author":"Samsoondar","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118726_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105415","article-title":"Impact of Atorvastatin on Skeletal Muscle Mitochondrial Activity, Locomotion and Axonal Excitability-Evidence from ApoE(-\/-) Mice","volume":"23","author":"Macchi","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118726_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0021-9150(99)00081-7","article-title":"Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice","volume":"145","author":"Caligiuri","year":"1999","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.biopha.2025.118726_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202200367","article-title":"Effect of Diets on Plasma and Aorta Lipidome: A Study in the apoE Knockout Mouse Model","volume":"67","author":"Busnelli","year":"2023","journal-title":"Mol. Nutr. Food Res"},{"issue":"7","key":"10.1016\/j.biopha.2025.118726_bib18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/ATVBAHA.122.317790","article-title":"Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia","volume":"42","author":"Busnelli","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118726_bib19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/a-1678-4031","article-title":"Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte Recruitment","volume":"122","author":"Busnelli","year":"2022","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.biopha.2025.118726_bib20","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/ATV.0000000000000062","article-title":"Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association","volume":"37","author":"Daugherty","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118726_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104435","article-title":"Monocarboxylate transporter 1 deficiency impacts CD8(+) T lymphocytes proliferation and recruitment to adipose tissue during obesity","volume":"25","author":"Macchi","year":"2022","journal-title":"iScience"},{"issue":"18","key":"10.1016\/j.biopha.2025.118726_bib22","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/cvr\/cvad169","article-title":"The inhibition of inner mitochondrial fusion in hepatocytes reduces non-alcoholic fatty liver and improves metabolic profile during obesity by modulating bile acid conjugation","volume":"119","author":"Da Dalt","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118726_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.mcn.2007.12.009","article-title":"Altered peripheral myelination in mice lacking GABAB receptors","volume":"37","author":"Magnaghi","year":"2008","journal-title":"Mol. Cell Neurosci."},{"issue":"8","key":"10.1016\/j.biopha.2025.118726_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ejhg.2008.21","article-title":"How much is too much? Phenotypic consequences of Rai1 overexpression in mice","volume":"16","author":"Girirajan","year":"2008","journal-title":"Eur. J. Hum. Genet"},{"key":"10.1016\/j.biopha.2025.118726_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117492","article-title":"Effect of statins on mitochondrial function and contractile force in human skeletal and cardiac muscle","volume":"180","author":"Somers","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.biopha.2025.118726_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2015.08.002","article-title":"Statin-Induced Myopathy Is Associated with Mitochondrial Complex III Inhibition","volume":"22","author":"Schirris","year":"2015","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2025.118726_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174125","article-title":"High-dose atorvastatin therapy progressively decreases skeletal muscle mitochondrial respiratory capacity in humans","volume":"9","author":"Ryan","year":"2024","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.biopha.2025.118726_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jacc.2013.02.074","article-title":"Simvastatin impairs exercise training adaptations","volume":"62","author":"Mikus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118726_bib29","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","article-title":"Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1","volume":"33","author":"Bouitbir","year":"2012","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.biopha.2025.118726_bib30","doi-asserted-by":"crossref","first-page":"C1208","DOI":"10.1152\/ajpcell.00226.2006","article-title":"Statin-induced apoptosis and skeletal myopathy","volume":"291","author":"Dirks","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"32","key":"10.1016\/j.biopha.2025.118726_bib31","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.biopha.2025.118726_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jech.2009.091033","article-title":"Adherence and chemoprevention in major cardiovascular disease: a simulation study of the benefits of additional use of statins","volume":"64","author":"Shroufi","year":"2010","journal-title":"J. Epidemiol. Community Health"},{"issue":"8","key":"10.1016\/j.biopha.2025.118726_bib33","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/eurheartj\/ehab718","article-title":"Combination lipid-lowering therapy as first-line strategy in very high-risk patients","volume":"43","author":"Ray","year":"2022","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.biopha.2025.118726_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.ATV.0000128849.12617.f4","article-title":"Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress","volume":"24","author":"Meir","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118726_bib35","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10557-023-07474-9","article-title":"The Clinical Efficacy and Safety of Bempedoic Acid in Patients at Elevated Risk of Cardiovascular Disease: A Meta-Analysis of Randomized Clinical Trials","volume":"38","author":"Sayed","year":"2024","journal-title":"Cardiovasc Drugs Ther."},{"issue":"4","key":"10.1016\/j.biopha.2025.118726_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2131\/jts.36.445","article-title":"Cerivastatin induces type-I fiber-, not type-II fiber-, predominant muscular toxicity in the young male F344 rats","volume":"36","author":"Obayashi","year":"2011","journal-title":"J. Toxicol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118726_bib37","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s002280050562","article-title":"Statins and peripheral neuropathy","volume":"54","author":"Jeppesen","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118726_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneumeth.2017.05.014","article-title":"The 9\u20135 Rodent - Time for Change? Scientific and animal welfare implications of circadian and light effects on laboratory mice and rats","volume":"300","author":"Hawkins","year":"2018","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.biopha.2025.118726_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cmet.2024.10.014","article-title":"Bempedoic acid suppresses diet-induced hepatic steatosis independently of ATP-citrate lyase","volume":"37","author":"Liu","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2025.118726_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2025.04.002","article-title":"Molecular targets of bempedoic acid and related decoy fatty acids","author":"Supplee","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.biopha.2025.118726_bib41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41580-022-00506-6","article-title":"Mechanisms of mitochondrial respiratory adaptation","volume":"23","author":"Bennett","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118726_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176085","article-title":"Low-dose atorvastatin protects skeletal muscle mitochondria in high-fat diet-fed mice with mitochondrial autophagy inhibition and fusion enhancement","volume":"959","author":"Zheng","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118726_bib43","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/ATVBAHA.116.306874","article-title":"Do the Apoe-\/- and Ldlr-\/- Mice Yield the Same Insight on Atherogenesis?","volume":"36","author":"Getz","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"22","key":"10.1016\/j.biopha.2025.118726_bib44","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1161\/CIRCULATIONAHA.123.067691","article-title":"Impact of Bempedoic Acid on Cardiovascular Outcomes by Sex","volume":"149","author":"Cho","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.biopha.2025.118726_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jacc.2024.04.048","article-title":"Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs","volume":"84","author":"Lincoff","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.biopha.2025.118726_bib46","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/eurjpc\/zwaf237","article-title":"Review of strategies to improve adherence to lipid-lowering therapy in the primary prevention of cardiovascular disease","volume":"32","author":"Whitmore","year":"2025","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225009205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:01:02Z","timestamp":1777014062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225009205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S0753332225009205"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118726","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of ATP citrate lyase does not affect muscle mitochondrial activity in apoE-\/- mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118726"}}